BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Farmers Insurance
Cerilliant
Covington
Accenture
UBS
Express Scripts
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim

Generated: January 18, 2018

DrugPatentWatch Database Preview

Medpointe Pharm Hlc Company Profile

« Back to Dashboard

What is the competitive landscape for MEDPOINTE PHARM HLC, and what generic and branded alternatives to MEDPOINTE PHARM HLC drugs are available?

MEDPOINTE PHARM HLC has twenty approved drugs.



Summary for Medpointe Pharm Hlc
US Patents:0
Tradenames:18
Ingredients:17
NDAs:20

Drugs and US Patents for Medpointe Pharm Hlc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc MILTOWN meprobamate TABLET;ORAL 009698-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc MILPREM-200 estrogens, conjugated; meprobamate TABLET;ORAL 011045-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc MILPREM-400 estrogens, conjugated; meprobamate TABLET;ORAL 011045-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc RONDOMYCIN methacycline hydrochloride SYRUP;ORAL 060641-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc DIUTENSEN-R methyclothiazide; reserpine TABLET;ORAL 012708-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc AQUATENSEN methyclothiazide TABLET;ORAL 017364-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc COLONAID atropine sulfate; diphenoxylate hydrochloride TABLET;ORAL 085737-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc DORMATE mebutamate TABLET;ORAL 017374-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-003 Dec 28, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Medpointe Pharm Hlc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-001 Dec 28, 1990 ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-002 Dec 28, 1990 ➤ Subscribe ➤ Subscribe
Medpointe Pharm Hlc BEPADIN bepridil hydrochloride TABLET;ORAL 019001-003 Dec 28, 1990 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Harvard Business School
US Department of Justice
Fuji
Cipla
Daiichi Sankyo
Julphar
McKesson
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot